Compounds > 6-ketoprostaglandin-f1-alpha

6-ketoprostaglandin-f1-alpha and vanadyl-sulfate

6-ketoprostaglandin-f1-alpha has been researched along with vanadyl-sulfate* in 1 studies

Other Studies

1 other study(ies) available for 6-ketoprostaglandin-f1-alpha and vanadyl-sulfate

Article	Year
Sodium tungstate and vanadyl sulfate effects on blood pressure and vascular prostanoids production in fructose-overloaded rats. Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:7 This study analyzes the effects of sodium tungstate and vanadyl sulphate in the fructose-overloaded rat, a model of metabolic syndrome. Fructose (9 weeks) increased blood pressure, triglycerydemia, glycemia, and reduced release of vasodilator prostaglandins (prostacyclin and prostaglandin E2 ) in the mesenteric vascular bed. Sodium tungstate prevented those alterations; meanwhile vanadyl sulfate only prevented the increase in glycemia. In conclusion, the present experiments showed that sodium tungstate is more effective than vanadyl sulfate for the treatment of experimental metabolic syndrome in rats. Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Blood Pressure Determination; Chromatography, Reverse-Phase; Dinoprostone; Disease Models, Animal; Endothelium, Vascular; Fructose; Hypertension; Male; Mesenteric Arteries; Mesenteric Veins; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Factors; Triglycerides; Tungsten Compounds; Vanadium Compounds	2010

Article

Year

Sodium tungstate and vanadyl sulfate effects on blood pressure and vascular prostanoids production in fructose-overloaded rats.

Clinical and experimental hypertension (New York, N.Y. : 1993), 2010, Volume: 32, Issue:7

This study analyzes the effects of sodium tungstate and vanadyl sulphate in the fructose-overloaded rat, a model of metabolic syndrome. Fructose (9 weeks) increased blood pressure, triglycerydemia, glycemia, and reduced release of vasodilator prostaglandins (prostacyclin and prostaglandin E2 ) in the mesenteric vascular bed. Sodium tungstate prevented those alterations; meanwhile vanadyl sulfate only prevented the increase in glycemia. In conclusion, the present experiments showed that sodium tungstate is more effective than vanadyl sulfate for the treatment of experimental metabolic syndrome in rats.

Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Blood Pressure Determination; Chromatography, Reverse-Phase; Dinoprostone; Disease Models, Animal; Endothelium, Vascular; Fructose; Hypertension; Male; Mesenteric Arteries; Mesenteric Veins; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Risk Factors; Triglycerides; Tungsten Compounds; Vanadium Compounds

2010